Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Find Protein Biomarker for Metastasis

February 4, 2011 6:03 am | News | Comments

Researchers at the National Institutes of Health and the University of Hong Kong have discovered that high levels of a particular protein in cancer cells are a reliable indicator that a cancer will spread.

TOPICS:

Vertex Loses $180M in Q4

February 4, 2011 5:47 am | News | Comments

Vertex Pharmaceuticals Inc. reported a larger fourth-quarter loss as it spent more money to develop its hepatitis C drug candidate telaprevir, along with a potential cystic fibrosis treatment and other drugs.

TOPICS:

Multichannel Pipetting Head

February 4, 2011 5:39 am | Product Releases | Comments

Hamilton Robotics introduces a 1 mL 96-channel pipetting head for its MICROLAB STAR and NIMBUS liquid handling workstations. Incorporating Hamilton’s CO-RE technology, the new 1 mL multi-pipetting head offers a higher dynamic pipetting range.

TOPICS:
Advertisement

Microplate Handling Robot

February 4, 2011 5:10 am | Product Releases | Comments

Agilent Technologies Inc. announced the addition of the BenchBot Robot to its line of automated microplate handling equipment. The BenchBot is a mid-sized microplate handler designed to meet the automation workflow needs of diverse laboratories.

TOPICS:

Protein Purification Platform

February 3, 2011 7:50 am | Product Releases | Comments

Agilent Technologies Inc. announced the launch of the AssayMAP Bravo platform and protein purification cartridges, a fully automated solution for high-throughput protein sample preparation and purification.

TOPICS:

Over 4,400 Attend LabAutomation2011

February 3, 2011 7:45 am | News | Comments

LabAutomation2011, the world’s leading conference and exhibition on emerging laboratory automation technologies, welcomed 4,407 participants from around the world to the Palm Springs Convention Center, Palm Springs, CA, USA, January 29-February 2, 2011.

TOPICS:

RT-PCR Assay

February 3, 2011 7:39 am | Product Releases | Comments

Bio-Rad Laboratories, Inc.'s newly released EpiQ chromatin analysis kit is a real-time PCR assay for the rapid quantitative assessment of chromatin structure.

TOPICS:

Cloud-based Sequencing Analysis

February 3, 2011 7:34 am | Product Releases | Comments

DNAnexus, Inc. announced the availability of a comprehensive set of new informatics tools that enable life science researchers to efficiently analyze and manage large-scale genomic variation datasets in a cloud-based workflow.

TOPICS:
Advertisement

Calipers And HIHG Collaborating on Gene Studies

February 3, 2011 7:32 am | News | Comments

Caliper Life Sciences, Inc. announced a collaboration with the John P. Hussman Institute for Human Genomics to develop automated protocols for exome capture and library preparation workflows.

TOPICS:

Lilly And JDRF Funding Regenerative Research

February 3, 2011 7:28 am | News | Comments

Eli Lilly and Company and the Juvenile Diabetes Research Foundation (JDRF) announced that they have signed an agreement to fund early-stage research that could enable patients with type 1 diabetes to regenerate insulin-producing cells destroyed by the disease.

TOPICS:

Losartan Improves Cancer Nanotherapies

February 3, 2011 7:22 am | News | Comments

A new report indicates that low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment.

TOPICS:

Scientists Urge More Black Box Consistency

February 3, 2011 7:19 am | News | Comments

A new study highlights inconsistencies in black box warnings and argues for a more transparent and systematic approach to ensure these warnings are consistent across all drugs within the same category.

TOPICS:

DSC127 Meets Trial Goals

February 3, 2011 7:15 am | News | Comments

Derma Sciences, Inc. announced positive results from its Phase 2 clinical trial with DSC127 in patients with diabetic foot ulcers, including meeting the trial’s primary endpoint, the proportion of study ulcers healed by 12 weeks.

TOPICS:

Valeant Paying $300M for Zovirax

February 3, 2011 7:09 am | News | Comments

Valeant Pharmaceuticals International Inc. said that its Biovail unit will pay $300 million for U.S. and Canadian rights for non-eye-care uses for GlaxoSmithKline's Zovirax. Zovirax is an antiviral cream.

TOPICS:

S & P May Downgrade Sanofi Credit

February 3, 2011 7:07 am | News | Comments

Standard & Poor's Ratings Services said that its credit ratings on Sanofi-Aventis SA remain on watch for possible downgrade pending the outcome of the French drugmaker's proposed bid for biotechnology company Genzyme Corp.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading